Stay updated with breaking news from Stage Celltech Developer Dedicated. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NASDAQ Biotech AVCO makes Big Moves Filing 16 Patent Applications, Co-Inventors are leading Universities & Cellular Therapy Developers; Avalon Globocare $AVCO
AVCO’s Filtration Tech Could Help Stop Life-Threatening Cytokine Storm in COVID-19 Patients
AVCO’s Chairman Converts $3.0 million of debt into common stock at $1.25 per share showing continued confidence and support of the business.
This new approach is advancing our capabilities in designing novel immuno-oncology and cellular